100
Participants
Start Date
August 30, 2017
Primary Completion Date
May 16, 2018
Study Completion Date
May 16, 2018
Tigerase®
2.5 mL (2.5 mg) dornase alfa nebulized once daily for 168 (+/-7) days
Pulmozyme®
2.5 mL (2.5 mg) dornase alfa nebulized once daily for 168 (+/-7) days
City Clinical Hospital named after D.D. Pletnev, Moscow
"Children's Clinical Hospital No. 1 , Cystic Fibrosis center", Yaroslavl
Clinical hospital No. 2, Yaroslavl
City Multidisciplinary Hospital No. 2, Saint Petersburg
Crimean federal university named after V.I.Vernadsky, Simferopol
Scientific medical center of General Medicine and pharmacologies, Stavropol
Volgograd State Medical University, Department of clinical pharmacology and intensive care, Volgograd
Regional clinical Hospital, Saratov
Kazan state medical University of Ministry of health, Hospital Therapy Department, Kazan'
Republican Clinical hospital named after G.G. Kuvatov, Ufa
Chelyabinsk Regional Clinical hospital, Chelyabinsk
Sverdlovsk Regional clinical hospital No. 1, Yekaterinburg
Tomsk national medical research Center of the Russian Academy of Sciences, Genetic Clinic Research Institute medical genetics, Tomsk
Regional Clinical Hospital, Barnaul
AO GENERIUM
INDUSTRY